Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

Medtronic (NYSE:MDT) today announced CE mark approval and the first commercial European implants for its OmniaSecure system.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...

Medtronic was the only manufacturer of a leadless pacemaker in the U.S. market in the years after it won approval for its Micra device in 2016. While leadless pacemakers were designed to prevent lead- ...

The first-of-its-kind Aurora EV-ICD system offers a single-device, single procedure with a lead placed outside of the heart and veins. The FDA has approved the Aurora Extravascular Implantable ...

Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...

TEL AVIV (MarketWatch) -- Medtronic Inc., the Minneapolis medical-technology company, said on Monday that it would voluntarily suspend distribution of the Sprint Fidelis family of defibrillation leads ...

Medtronic has issued a warning about rapid unexpected battery depletion that may happen in seven kinds of implantable defibrillators, affecting nearly 340,000 implanted devices worldwide. The Food and ...